Atlas Trials

Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial NCT01743807 · TERMINATED

Trial details

NCT number
NCT01743807
Sponsor
Therapeutic Advances in Childhood Leukemia Consortium
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed Acute Lymphoblastic LeukemiaRelapsed Acute Myelogenous Leukemia
Start date
2014-03-26
Primary completion
2014-07-28
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.